Beijing New Oriental Star Petrochemical Engineering Co Ltd - Asset Resilience Ratio
Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has an Asset Resilience Ratio of 24.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 002755 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Beijing New Oriental Star Petrochemical Engineering Co Ltd's Asset Resilience Ratio has changed over time. See Beijing New Oriental Star Petrochemical (002755) net asset quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Beijing New Oriental Star Petrochemical Engineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Beijing New Oriental Star Petrochemical worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.09 Billion | 24.59% |
| Total Liquid Assets | CN¥1.09 Billion | 24.59% |
Asset Resilience Insights
- Good Liquidity Position: Beijing New Oriental Star Petrochemical Engineering Co Ltd maintains a healthy 24.59% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing New Oriental Star Petrochemical Engineering Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
SIMCERE PHARMAC. GRP LTD
F:S2P |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Chongqing Taiji Industry Group Co Ltd
SHG:600129 |
Drug Manufacturers - Specialty & Generic | 0.47% |
Annual Asset Resilience Ratio for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing New Oriental Star Petrochemical Engineering Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 16.88% | CN¥683.28 Million ≈ $99.99 Million |
CN¥4.05 Billion ≈ $592.30 Million |
-3.38pp |
| 2023-12-31 | 20.26% | CN¥713.83 Million ≈ $104.46 Million |
CN¥3.52 Billion ≈ $515.65 Million |
-4.32pp |
| 2022-12-31 | 24.57% | CN¥839.08 Million ≈ $122.78 Million |
CN¥3.41 Billion ≈ $499.63 Million |
+10.55pp |
| 2021-12-31 | 14.02% | CN¥522.39 Million ≈ $76.44 Million |
CN¥3.72 Billion ≈ $545.05 Million |
+11.40pp |
| 2020-12-31 | 2.63% | CN¥100.00 Million ≈ $14.63 Million |
CN¥3.81 Billion ≈ $557.24 Million |
-0.08pp |
| 2019-12-31 | 2.71% | CN¥100.00 Million ≈ $14.63 Million |
CN¥3.69 Billion ≈ $540.27 Million |
+1.69pp |
| 2018-12-31 | 1.01% | CN¥30.00 Million ≈ $4.39 Million |
CN¥2.96 Billion ≈ $432.89 Million |
-79.94pp |
| 2015-12-31 | 80.96% | CN¥580.00 Million ≈ $84.87 Million |
CN¥716.42 Million ≈ $104.84 Million |
-- |
About Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more